Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)
作者： Amar Gajjar , Giles W. Robinson , Kyle S. Smith , Tong Lin , Thomas E. Merchant
DOI: 10.1200/JCO.20.01372
关键词: MEDLINE 、 Oncology 、 Clinical significance 、 Medicine 、 Internal medicine 、 Medulloblastoma
摘要: PURPOSE SJMB03 (ClinicalTrials.gov identifier: NCT00085202 ) was a phase III risk-adapted trial that aimed to determine the frequency and clinical significance of biological variants …
scilit.net参考文章(0)